Searched for
ALEMBIC PHARMACEUTICALS NEWS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...
Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
Stocks in news: IRFC, Voltas, IDFC First Bank, Alembic Pharma, LupinMarkets declined sharply on Tuesday due to weak global cues, with the Nifty retesting crucial support near 25,400. Several stocks like IRFC...
Alembic Pharmaceuticals shares rise 2% after USFDA nod for key hypertension drugOn Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride Tablets, a crucial ...
Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major...
Stocks in news: Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtreePiramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issua...
Stocks in news: Ultratech, Paytm, L&T, Biocon, Alembic PharmaLarsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...
Alembic gets USFDA nod for generic skin treatment creamThe approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US LL...
Add Alembic Pharmaceuticals, target price Rs 695: ICICI SecuritiesAlembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating R...
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...
Reduce Alembic Pharmaceuticals, target price Rs 641: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 13347.62 Crore) operating in P...
Neutral on Alembic Pharmaceuticals, target price Rs 750: Motilal Oswal Financial ServicesAlembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...
Buy Alembic Pharmaceuticals, target price Rs 820: Yes SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 15335.85 Crore) operating in P...
Alembic Pharma tanks 10% after flop show in Q1Shares of Alembic Pharmaceuticals declined 10 per cent to Rs 822.60, its new 52-week low, on Tuesday.
US FDA finds quality control, equipment issues at Alembic Pharma unitEarlier this month, the US drug regulator had issued a ‘Form 483’ to the facility of the drug company with five observations.
Add Alembic Pharmaceuticals, target price Rs 1151: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 18770.80 Crore) operating in P...
Buy Alembic Pharmaceuticals, target price Rs 1180: Yes SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 19440.09 Crore) operating in P...
Alembic Pharma raises Rs 350 crore via NCDsThe co said it has also allotted 2,000, 9% rated unsecured listed redeemable NCDs